These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26436201)

  • 41. Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
    Muir AJ; Poordad F; Lalezari J; Everson G; Dore GJ; Herring R; Sheikh A; Kwo P; Hézode C; Pockros PJ; Tran A; Yozviak J; Reau N; Ramji A; Stuart K; Thompson AJ; Vierling J; Freilich B; Cooper J; Ghesquiere W; Yang R; McPhee F; Hughes EA; Swenson ES; Yin PD
    JAMA; 2015 May; 313(17):1736-44. PubMed ID: 25942724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of HCV genotypes in Poland.
    Panasiuk A; Flisiak R; Mozer-Lisewska I; Adamek A; Tyczyno M; Halota W; Pawłowska M; Stańczak J; Berak H; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Łapiński TW; Grzeszczuk A; Piekarska A; Tomasiewicz K; Jabłkowski M; Kryczka W; Zarebska-Michaluk D; Stepień P; Garlicki AM; Kozłowska J; Wiercińska-Drapało A; Zasik E; Mazur W; Dobracka B; Dobracki W; Simon K; Ryzko J; Pawłowska J; Dzierzanowska-Fangrat K; Januszkiewicz-Lewandowska D; Szenborn L; Zaleska I; Rokitka M; Strawińska E; Balinowska K; Smiatacz T; Stalke P; Sikorska K; Lakomy A; Zdrojewski M; Lachowicz A
    Przegl Epidemiol; 2013; 67(1):11-6, 99-103. PubMed ID: 23745369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
    Alter MJ; Kruszon-Moran D; Nainan OV; McQuillan GM; Gao F; Moyer LA; Kaslow RA; Margolis HS
    N Engl J Med; 1999 Aug; 341(8):556-62. PubMed ID: 10451460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.
    Pedersen J; Lundbo LF; Krarup H; Bukh J; Weis N
    J Med Virol; 2016 Oct; 88(10):1791-803. PubMed ID: 27027386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changing HCV genotypes distribution in Poland--relation to source and time of infection.
    Chlabicz S; Flisiak R; Kowalczuk O; Grzeszczuk A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
    J Clin Virol; 2008 Jun; 42(2):156-9. PubMed ID: 18353714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
    Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F
    Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of liver disease in Korea: hepatitis C.
    Lim YS
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S25-8. PubMed ID: 20037276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Distribution of hepatitis C virus genotypes in Jeju Island].
    Lee H; Cho YK; Kim HU; Choi EK; Hyun S; Kang D; Jeong SU; Kim HJ; Kim KS; Song BC
    Korean J Hepatol; 2008 Mar; 14(1):28-35. PubMed ID: 18367855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of systematic administration of Filgrastim to prevent neutropenia and infections in patient with hepatitis C.
    Sharvadze L; Karchava M; Bolokadze N; Gatserelia L; Tsertsvadze T
    Georgian Med News; 2009 Oct; (175):32-5. PubMed ID: 19893121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of hepatitis C virus infection in American veterans.
    Cheung RC
    Am J Gastroenterol; 2000 Mar; 95(3):740-7. PubMed ID: 10710068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The next era of HCV antiviral therapy finally begins: part 2.
    Bobak D
    Curr Infect Dis Rep; 2010 Mar; 12(2):79-80. PubMed ID: 21308502
    [No Abstract]   [Full Text] [Related]  

  • 54. The next era of HCV antiviral therapy finally begins: part 1.
    Bobak D
    Curr Infect Dis Rep; 2010 Mar; 12(2):77-8. PubMed ID: 21308501
    [No Abstract]   [Full Text] [Related]  

  • 55. The dawn of a new era in the treatment of HCV infection: A view from the USA.
    Pockros PJ
    Clin Liver Dis (Hoboken); 2014 Nov; 4(5):107-108. PubMed ID: 30992933
    [No Abstract]   [Full Text] [Related]  

  • 56. The chronic disease era.
    RYDER CF
    J Miss State Med Assoc; 1963 Mar; 4():96-101. PubMed ID: 13975804
    [No Abstract]   [Full Text] [Related]  

  • 57. ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
    Maan R; van der Meer AJ; Brouwer WP; Plompen EP; Sonneveld MJ; Roomer R; van der Eijk AA; Groothuismink ZM; Hansen BE; Veldt BJ; Janssen HL; Boonstra A; de Knegt RJ
    PLoS One; 2015; 10(10):e0139317. PubMed ID: 26441325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiological trends among the population with chronic HCV infection in the Netherlands.
    Maan R; Toes-Zoutendijk E; Veldt BJ; Hansen BE; van der Meer AJ; de Knegt RJ
    Antivir Ther; 2016; 21(3):207-15. PubMed ID: 26436201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.